1.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MMC-03-02-040, NCT00231842
|
|
2.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2006-0453, NCT00414076
|
|
3.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Any age Sponsor: NCI Protocol IDs: CINJ-3330, NCT00161187
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 06-063, NCT00476086
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: WalkerIP, NCT00582205
|
|
6.
|
Phase: Phase I Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: TRC105499, NCT00358540
|
|
7.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 06C.549, NCT00437372
|
|
8.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: NYU 05-409, NCT00821652
|
|
9.
|
Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: TAMC 3H04, NCT00160472
|
|
10.
|
Phase: No phase specified Type: Natural history/Epidemiology, Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: 2003-0962, NCT00415675
|
|
11.
|
Phase: No phase specified Type: Health services research, Treatment Status: Active Age: 21 and over Sponsor: Other Protocol IDs: 08-092, NCT00746018
|